Company Profile
ANI Pharmaceuticals Stock Price, News & Catalysts
- Ticker:
- ANIP
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
76.00 USD (-0.71%)
Close
Last updated: August 17, 2026
1.7B USD
Market cap
Why the stock is moving
As of Aug 17, 2026, ANIP closed down 0.71% at $76.00. No new same-company headline was identified in the current news window.
Company overview
Rare-Disease and Specialty Pharmaceuticals
ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets. Its model combines branded specialty products with a portfolio of generic medicines.
Cortrophin Gel
Purified Cortrophin Gel is an adrenocorticotropic hormone therapy used across selected autoimmune and inflammatory indications. It is the primary growth driver of ANI's rare-disease franchise.
Ophthalmology Portfolio
ILUVIEN and YUTIQ are sustained-release fluocinolone implants for retinal diseases, including diabetic macular edema and chronic noninfectious uveitis affecting the posterior segment.
Future catalysts
- Phase 4 SYNCHRONICITY results in noninfectious uveitis at a medical conference in the third quarter of 2026.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ANI Pharmaceuticals (ANIP)?
ANI Pharmaceuticals (ANIP) most recently closed at 76.00 USD, a -0.71% move versus the previous session.
What is the market cap of ANI Pharmaceuticals (ANIP)?
ANI Pharmaceuticals currently has a market capitalization of 1.7B USD on BioPharmSignal.
What does ANI Pharmaceuticals do?
Rare-Disease and Specialty Pharmaceuticals ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets. Its model combines branded specialty products with a portfolio of generic medicines. Cortrophin Gel Purified Cortrophin Gel is an adrenocorticotropic hormone therapy used across...
On which exchange is ANIP stock listed?
ANI Pharmaceuticals (ANIP) is associated with NASDAQ, United States, Biopharma.
What is Rare-Disease?
Rare-Disease and Specialty Pharmaceuticals ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets.
Which conditions is ANI Pharmaceuticals targeting with Rare-Disease?
ANI Pharmaceuticals is associated with rare disease, ophthalmology based on its company overview and current catalyst commentary.
How does ANI Pharmaceuticals describe recent progress with Rare-Disease?
Phase 4 SYNCHRONICITY results in noninfectious uveitis at a medical conference in the third quarter of 2026.
What is Specialty?
Rare-Disease and Specialty Pharmaceuticals ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets.